#1 Clinical Trials Search in Europe

Ethambutol

This article examines the use of ethambutol in clinical trials for treating various mycobacterial infections, particularly tuberculosis and Mycobacterium avium complex (MAC). Ethambutol is an important antibiotic that is often used in combination with other drugs to combat these challenging infections. The trials discussed here aim to optimize treatment regimens, evaluate efficacy and safety, and compare ethambutol-containing combinations to alternative therapies.

Table of Contents

What is Ethambutol?

Ethambutol is an antibiotic medication used primarily to treat various types of mycobacterial infections. It is also known by the brand names Myambutol, Dexambutol, and Inbutol[1][2]. This drug plays a crucial role in combating serious bacterial infections, particularly those caused by mycobacteria.

Uses of Ethambutol

Ethambutol is primarily used to treat the following conditions:

  • Tuberculosis (TB): Ethambutol is a key component in the treatment of pulmonary tuberculosis, a serious lung infection caused by Mycobacterium tuberculosis[3].
  • Mycobacterium Avium Complex (MAC) infections: This includes lung infections caused by bacteria in the MAC group, which are common in people with weakened immune systems, such as those with HIV/AIDS[1].
  • Other nontuberculous mycobacterial infections: Ethambutol can be effective against various other mycobacterial species that cause lung or disseminated infections[4].

How Ethambutol Works

Ethambutol works by interfering with the ability of mycobacteria to build their cell walls. This action stops the bacteria from growing and multiplying, allowing the body’s immune system to fight off the infection more effectively. It’s important to note that ethambutol is typically used in combination with other antibiotics to prevent the development of drug-resistant bacteria[3].

Dosage and Administration

The dosage of ethambutol can vary depending on the specific condition being treated, the patient’s weight, and other factors. Generally, it is taken orally once daily. Here’s an example of a common dosing regimen for tuberculosis treatment[5]:

  • 40-55 kg body weight: 800 mg (two 400 mg tablets)
  • 56-75 kg body weight: 1,200 mg (three 400 mg tablets)
  • 76-90 kg body weight: 1,600 mg (four 400 mg tablets)
  • Over 90 kg: 1,600 mg (four 400 mg tablets)

It’s crucial to take ethambutol exactly as prescribed by your healthcare provider. The duration of treatment can range from several months to years, depending on the infection being treated and how well you respond to therapy.

Ethambutol in Combination Therapy

Ethambutol is rarely used alone. It is typically part of a combination therapy regimen to treat mycobacterial infections effectively. Some common combinations include:

  • For tuberculosis: Ethambutol is often combined with isoniazid, rifampicin, and pyrazinamide[3].
  • For MAC infections: Ethambutol is frequently used with a macrolide antibiotic (such as clarithromycin or azithromycin) and rifampicin or rifabutin[1].

These combination therapies help prevent the development of drug-resistant bacteria and increase the overall effectiveness of treatment.

Side Effects and Monitoring

While ethambutol is generally well-tolerated, it can cause side effects. The most significant concern is its potential to affect vision. Therefore, regular eye examinations are crucial during treatment. Common side effects may include[2]:

  • Changes in color vision
  • Blurred vision
  • Decreased visual acuity
  • Nausea or vomiting
  • Abdominal pain
  • Headache
  • Dizziness
  • Skin rash

Your healthcare provider will likely schedule regular check-ups to monitor for these side effects and may perform blood tests to check your liver function. It’s important to report any changes in vision or other unusual symptoms to your doctor immediately.

Ongoing Research

Ethambutol continues to be the subject of ongoing research to improve its use and effectiveness. Some areas of current study include:

  • Optimal dosing strategies: Researchers are investigating how factors like body weight and obesity affect ethambutol concentrations in the body to optimize dosing[5].
  • Combination therapies: Studies are exploring new combinations of antibiotics, including ethambutol, to improve treatment outcomes for various mycobacterial infections[1][3].
  • Alternative administration methods: Some research is looking into the effectiveness of intravenous ethambutol compared to oral administration for certain types of tuberculosis[2].
  • Long-term outcomes: Researchers are studying the long-term effects and outcomes of ethambutol-containing treatments for various mycobacterial infections[4].

These ongoing studies aim to improve the effectiveness of ethambutol and reduce potential side effects, ultimately leading to better outcomes for patients with mycobacterial infections.

Aspect Details
Primary Uses Treatment of tuberculosis (TB) and Mycobacterium avium complex (MAC) infections
Administration Oral tablets, typically dosed based on body weight (15-25 mg/kg/day)
Common Combinations With isoniazid, rifampin, and pyrazinamide for TB; with macrolides and rifampin for MAC
Treatment Duration Varies; 6 months for standard TB treatment, 12-18+ months for MAC infections
Key Side Effects Vision changes, liver function abnormalities, gastrointestinal issues
Monitoring Regular eye exams, liver function tests, sputum cultures
Research Focus Optimizing dosing, comparing efficacy to other regimens, evaluating safety in various populations

FAQ

  • What is ethambutol used to treat? Ethambutol is primarily used to treat mycobacterial infections, including tuberculosis (TB) and Mycobacterium avium complex (MAC) infections. It is typically used in combination with other antibiotics as part of a multi-drug regimen.
  • How is ethambutol typically administered? Ethambutol is usually taken orally as a tablet. The dosage is often based on body weight, with common doses ranging from 15-25 mg/kg per day. In some trials, it is administered daily, while in others it may be given three times per week.
  • What are some common side effects of ethambutol? Common side effects of ethambutol can include vision changes, such as decreased visual acuity or color vision. Regular eye exams are often recommended during treatment. Other potential side effects may include liver function abnormalities, gastrointestinal issues, and skin reactions.
  • How long do patients typically take ethambutol? The duration of ethambutol treatment varies depending on the specific infection and treatment regimen. For tuberculosis, it may be part of a 6-month standard treatment course. For MAC infections, treatment duration can be longer, often 12-18 months or more.
  • Is ethambutol used alone or in combination with other drugs? Ethambutol is almost always used in combination with other antibiotics to prevent the development of drug resistance. Common combinations include ethambutol with isoniazid, rifampin, and pyrazinamide for TB, or with macrolides (like azithromycin or clarithromycin) and rifampin for MAC infections.

Ongoing Clinical Trials on Ethambutol

  • Study on the Effects of Tedizolid and Linezolid for Patients with Suspected Lung Tuberculosis

    Recruiting

    2 1 1 1
    Investigated drugs:
    France

  • Study on the Effectiveness of Clofazimine and Drug Combination for Treating Mycobacterium abscessus Lung Disease in Adult Patients

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

Glossary

  • Mycobacterium avium complex (MAC): A group of bacteria that can cause lung infections, especially in people with weakened immune systems. MAC infections are often challenging to treat and require long-term antibiotic therapy.
  • Tuberculosis (TB): A bacterial infection caused by Mycobacterium tuberculosis that primarily affects the lungs but can also impact other parts of the body. TB requires a long course of antibiotic treatment.
  • Sputum culture conversion: When a person with a positive sputum culture (indicating active TB or other mycobacterial infection) later has negative cultures, showing that the treatment is working to clear the infection.
  • Pharmacokinetics: The study of how drugs move through the body, including how they are absorbed, distributed, metabolized, and eliminated. This helps determine proper dosing and potential drug interactions.
  • Adverse event: Any unfavorable and unintended sign, symptom, or disease that occurs during treatment, whether or not it is considered to be related to the medication being studied.
  • Randomized controlled trial: A type of clinical study where participants are randomly assigned to different treatment groups to compare the effectiveness of different interventions.
  • Non-inferiority trial: A type of clinical trial designed to demonstrate that a new treatment is not worse than a standard treatment by more than a pre-specified margin.
  • Bronchiectasis: A condition where the airways of the lungs become damaged and abnormally widened, leading to mucus buildup and increased risk of infections.
  • Macrolide: A class of antibiotics that includes drugs like azithromycin and clarithromycin, often used in combination with ethambutol to treat mycobacterial infections.
  • Rifampin: An antibiotic commonly used in combination with ethambutol and other drugs to treat tuberculosis and other mycobacterial infections.

References

  1. https://clinicaltrials.gov/study/NCT03236987
  2. https://clinicaltrials.gov/study/NCT04150367
  3. https://clinicaltrials.gov/study/NCT01994460
  4. https://clinicaltrials.gov/study/NCT03672630
  5. https://clinicaltrials.gov/study/NCT01048697